HIV -1 Infection: Clinical Trials

3 trials for HIV -1 Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Recruiting 2, Not yet recruiting 1

Follow HIV -1 Infection: new trials by email Literature Review of HIV -1 Infection trials Research Report on HIV -1 Infection

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study
Oral Methamphetamine, Placebo oral capsule - HIV -1 Infection, Methamphetamine Use
Phase 4Not yet recruitingUniversity of California, San Francisco202026-10-012026-08-17
Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
Every 4-week long-acting injectable cabotegravir and rilpivirine - HIV -1 Infection
Phase 4RecruitingInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group402026-10-012026-11-03
REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Bictegravir, emtricitabine, and tenofovir alafenamide - HIV -1 Infection, HIV (Human Immunodeficiency Virus)
Phase 4RecruitingCAN Community Health2002026-06-172026-09-03

Narrower conditions

Acquired Immunodeficiency Syndrome (1)  ·  HIV Infections (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Slow Virus Diseases (1)  ·  Urogenital Diseases (1)  ·  Virus Diseases (1)

Interventions

Methamphetamine (1)  ·  Rilpivirine (1)  ·  bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1)

Sponsors

CAN Community Health (1)  ·  International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1)  ·  University of California, San Francisco (1)

Countries

United States (3)

Top investigators

Hector Bolivar, MD (1)  ·  Jessica Altamirano, MD (1)  ·  Rachel Scott, MD, MPH (1)  ·  Sulggi Lee, MD, PhD (1)

NIH funding

RM1DA063218 (1), UM1AI068616 (1), UM1AI068632 (1), UM1AI106716 (1)